Furthermore, Kawasaki disease and secondary coronary artery lesions are found to be associated with ADAM17 genetic variants through TGF-β/Smad3 signaling pathway (Peng et al., 2016). This evidence concerns the gene TGFB1 and Kawasaki disease.